Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegliposomal Doxorubicin and 5-FU in Metastatic Gastric Cancer
NCT04358341Phase 2Unknown
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in gastric cancer (GC), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04358341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04358341.